PFC
IRWD icon

Phocas Financial Corp’s Ironwood Pharmaceuticals IRWD Stock Holding History

Phocas Financial Corp’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-141,427
Closed -$1.23K – 141
2024
Q1 		$1.23K Buy
+141,427
New +$1.72M 0.01% 137
2023
Q1 		– Sell
-253,694
Closed -$3.14M – 243
2022
Q4 		$3.14M Sell
253,694
-257
-0.1% -$2.92K 0.45% 90
2022
Q3 		$2.63M Buy
+253,951
New +$2.88M 0.41% 102

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Phocas Financial Corp's IRWD Position: Q2 2024 in Review

Phocas Financial Corp sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2024, closing a stake of 141,427 shares — an estimated $1.23K sold.

Phocas Financial Corp first reported a position in IRWD in Q3 2022 and held it in 3 quarters. The position peaked at $3.14M in Q4 2022. 226 funds tracked by Wall St. Rank hold IRWD as of Q2 2024.

  • Phocas Financial Corp reported no remaining Ironwood Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Phocas Financial Corp sold 141,427 Ironwood Pharmaceuticals shares in Q2 2024, an estimated $1.23K.
  • Phocas Financial Corp first reported a position in Ironwood Pharmaceuticals in Q3 2022 and held it in 3 quarters.
  • Phocas Financial Corp's Ironwood Pharmaceuticals position peaked at $3.14M in Q4 2022.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2024.

Based on Phocas Financial Corp's 13F filing for Q2 2024, filed 24 Jul 2024.